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Abstract
Background: This study describes the prevalence of dementia and major dementia subtypes in
Spanish elderly.
Methods:  We identified screening surveys, both published and unpublished, in Spanish
populations, which fulfilled specific quality criteria and targeted prevalence of dementia in
populations aged 70 years and above. Surveys covering 13 geographically different populations were
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selected (prevalence period: 1990-2008). Authors of original surveys provided methodological
details of their studies through a systematic questionnaire and also raw age-specific data. Prevalence
data were compared using direct adjustment and logistic regression.
Results: The reanalyzed study population (aged 70 year and above) was composed of Central and
North-Eastern Spanish sub-populations obtained from 9 surveys and totaled 12,232 persons and
1,194 cases of dementia (707 of Alzheimer's disease, 238 of vascular dementia). Results showed
high variation in age- and sex-specific prevalence across studies. The reanalyzed prevalence of
dementia was significantly higher in women; increased with age, particularly for Alzheimer's disease;
and displayed a significant geographical variation among men. Prevalence was lowest in surveys
reporting participation below 85%, studies referred to urban-mixed populations and populations
diagnosed by psychiatrists.
Conclusion: Prevalence of dementia and Alzheimer's disease in Central and North-Eastern Spain
is higher in females, increases with age, and displays considerable geographic variation that may be
method-related. People suffering from dementia and Alzheimer's disease in Spain may approach
600,000 and 400,000 respectively. However, existing studies may not be completely appropriate to
infer prevalence of dementia and its subtypes in Spain until surveys in Southern Spain are
conducted.
Background
Spain is one of the fastest aging societies in the world.
According to the aging index, the proportion of the Span-
ish population aged 65 years and over (16.8% in 2004)
have doubled in the last 30 years ranking seventh among
European countries http://eurostat.eu.europa.eu. There-
fore, the burden of chronic neurodegenerative disorders,
particularly dementia, is expected to grow exponentially.
Dementia screening surveys are population-based studies
in which individuals that are screened positively through
a cognitive or disability test, undergo a second phase of
clinical assessment and diagnosis. The screening survey is
the only methodologically sound research design capable
of estimating dementia prevalence. It copes effectively
with bias due to underdiagnosis of dementia in the com-
munity.
A review by the Spanish Epidemiological Study Group on
Aging identified reports on age- and sex-specific preva-
lence of dementia from screening surveys referred to 6
populations conducted from 1990 to 2000 [1]. Crude
dementia prevalence for elders aged 70 years or more
ranged from 6.6% in Zaragoza to 17.2% in Pamplona.
Prevalences of Alzheimer's disease (AD) in these surveys
were 5.1% and 10.6%, respectively. Vascular dementia
(VD) was the second most frequent dementia subtype [1].
However, prevalence reported for Spanish populations by
2005 might be limited given the methodological differ-
ences across studies and the recent improvements in diag-
nostic criteria for infrequent dementia subtypes. In
addition, the above-mentioned surveys focused on popu-
lations resident in the Northern half of the country, while
Southern populations remain under-reported. The latter
might be particularly important given the higher vascular
mortality found in Southern Spain and the impact of vas-
cular factors in the etiology of dementia [2].
This study sought to 1) estimate the prevalence of demen-
tia in Spain reanalyzing the data from published and
unpublished dementia prevalence screening surveys con-
ducted to date, 2) identify study features related to the
magnitude of dementia prevalence, and 3) compare the
prevalence of dementia found in Spanish studies with that
of selected European surveys.
Methods
In this report, we followed the recommendations of the
Meta-analysis of Observational Studies in Epidemiology
Group [3] for the purposes of identifying, appraising, syn-
thesizing, and combining results from different surveys.
Search strategy
Studies on dementia prevalence in Spain were searched up
to December 31, 2008 in PubMed, Indice Médico Español
and Biblioteca Virtual en Salud. The following search
words were used as MeSH or TIAB terms: "dementia,"
"prevalence," "door-to-door," "screening" and "Europe."
Search was restricted to reports published in English and
Spanish within the period 1985 through 2008. Search
yielded 23 reports in English and 3 in Spanish. Upon
authors' request, the Spanish Society of Neurology and
the Spanish Society of Epidemiology provided informa-
tion about one ongoing survey in Murcia (Eastern Spain).
Studies selection
Inclusion and exclusion criteria for survey selection
approved by consensus by the Spanish EpidemiologicalBMC Neurology 2009, 9:55 http://www.biomedcentral.com/1471-2377/9/55
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Study Group on Aging were as follows: 1) survey incorpo-
rates an updated population census for a study popula-
tion geographically defined by residence, 2) survey uses a
screening instrument in the first phase of the study, 3) sur-
vey describes the diagnostic methods and the medical spe-
cialist in charge of diagnosis (e.g., geriatrician,
neurologist, psychologist); 4) survey uses specific diag-
nostic criteria for dementia subtypes; and 5) survey
includes no less than 20 dementia cases. Inclusion and
exclusion criteria assured a minimum quality threshold.
Surveys potentially valid for analysis finished data collec-
tion by October 2008. The pool of potentially valid sur-
veys included 1 pilot study [4], 14 published surveys [2-
19], and 1 unpublished survey [20]. The target popula-
tions of these studies were: Pamplona, Zaragoza-
ZARADEMP (two-time point measurements), NEDICES
(three geographically distinct sub-populations in Central
Spain), Toledo, Leganés, Gerona, La Selva del Camp,
Turégano, Alcoi/Bañeres, Bidasoa and Munguialde, El
Prat de Llobregat and Murcia.
Inclusion criteria were independently rated in each pre-
selected survey by three co-authors (RB, JLB and JPC)
through a questionnaire for data-collection, focusing on
demographic, methodological, diagnostic, disability-
related and epidemiologic data to be requested from the
authors of the selected surveys [5-11,13-21]. The
NEDICES survey and studies in La Selva del Camp and
Alcoi/Bañeres [8,13,14] were excluded due to incomplete
dataset. Authors of the ongoing study in Murcia [20]
refrained from participating before the publication of
their original data. Data from ZARADEMP first measure-
ment was not provided [21]. The pilot study by Bermejo-
Pareja [4] and a study reporting 11 dementia cases aged 
65 years [12] were excluded due to small sample size.
Nine studies covering 9 geographically different popula-
tions met inclusion criteria: Bidasoa, Munguialde,
Gerona, Leganés, Pamplona, El Prat de Llobregat, Toledo,
and Zaragoza, ZARADEMP one population each [5-7,9-
11,15-17,19]. Since some studies solely covered popula-
tions aged 70 years and over, the sub-populations used for
reanalysis of selected studies comprised subjects over the
age of 69 years, divided into 4, 5-year sex-specific strata,
and two open-ended groups aged  70 and  90 years
respectively.
The methodological characteristics of the selected surveys
are presented in Additional File 1. The geographical loca-
tions of the surveys covered by reanalysis are shown in
Figure 1. Prevalence years ranged from 1990 to 2005. The
population size ranged from 524 in Leganés to 2,850 in
ZARADEMP, and the number of cases went from 48 in
Bidasoa to 214 in ZARADEMP. Data on the size of the
municipalities where the participants lived was obtained
from the National Institute of Statistics http://
www.ine.es/. Municipalities were classified as rural
(<2,000 inhabitants) and urban ( 10,000 inhabitants).
Urban metropolitan populations with a high proportion
of immigrants, i.e., born outside the municipal bounda-
ries, were denoted as suburban. An urban mixed category
was used to identify former rural populations which had
become urban in recent decades.
Assessment of prevalence variation within Spanish 
reanalyzed surveys
Age- and age- and sex-specific prevalence of dementia and
major dementia subtypes were obtained for four 5-year
age groups and an open  90 years group. Crude preva-
lence proportions, as well as age- and sex-adjusted preva-
lence were calculated for the population aged  70 years.
We used the European standard population as the basis
for adjustment (weights 0.43, 0.29, 0.14 and 0.14 for 75-
79, 80-84 ad 85 and over years, respectively; http://
seer.cancer.gov/stdpopulations/stdpop.19ages.html.
For the purposes of assessing prevalence of dementia and
its major subtypes, data from reanalyzed surveys were
weighted against those of El Prat, which was taken as ref-
erence. El Prat was selected as reference due to its recency
and large study size [17]. Unconditional logistic regres-
sion on grouped data controlling for age and sex was con-
ducted. The prevalence variation in reanalyzed surveys by
environment (rural, urban), diagnosing specialists (psy-
chiatrist, neurologist, geriatricians) and percentage of par-
ticipation of targeted population, was assessed using the
same multivariate methods. Diagnosing specialist was
Geographical location of reported and not reported, reana- lyzed dementia prevalence surveys in Spain Figure 1
Geographical location of reported and not reported, 
reanalyzed dementia prevalence surveys in Spain.
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considered a predictive factor due to the different diagnos-
tic patterns among specialists with different backgrounds
[19]. All analyses were carried out with Stata v. 8.0 (Stata
Corporation, College Station, Texas).
Results
The combined population for reanalysis, hereafter Span-
ish-reanalyzed population, totaled 12,232 persons
(7,150, 58% women) and yielded 1,194 cases of demen-
tia; 707 AD cases, and 238 cases of VD. The Spanish-rean-
alyzed population came from North and Central Spain
and varied in terms of living environment. For instance,
while the Zaragoza, Gerona, and Pamplona surveys
focused on urban populations, those in Leganés and El
Prat were suburban with a high proportion of immigrant
population (~86%). Other sub-populations were less
homogeneous, e.g., the Bidasoa and Toledo areas had a
high proportion of immigrants and were both classified as
urban-mixed. Detailed age- and sex-specific prevalence of
dementia, as well as crude, and age- and sex-adjusted
counts for participants aged  70 years are shown in Addi-
tional File 2. Prevalence estimates of 9 and 8 sub-popula-
tions were available for AD and VD respectively. Age- and
sex-specific prevalences are presented in Figure 2.
Dementia prevalence varied substantially across surveys
in age-specific groups: up to four-fold increase among the
oldest group (Figure 2). Differences in crude prevalence
for participants aged  70 years were consistent across gen-
der and age groups (Figures 2), ranging from 3.5% in
Bidasoa to 17.2% in Pamplona. Age- and sex-adjusted
prevalence in the same age-group ranged from 3.2% in
Bidasoa to 12.3% in Gerona, while the corresponding fig-
ures in the El Prat survey were intermediate (9.6 and
9.3%).
In the case of AD both sexes, age- and sex-adjusted preva-
lence at age  70 years, ranged from 2.6% in ZARADEMP
to 7.7% in El Prat, and in the case of VD, from 1.2% in El
Prat and ZARADEMP to 5.1% in Gerona.
Insofar as Lewy body dementia (LBD) and frontotempo-
ral dementia (FTD) were concerned, little information
was available in the Spanish-reanalyzed population.
Crude LBD prevalence at  70 years was 2.0% in El Prat
and Bidasoa and 0.8%, including parkinsonism with
dementia in Muguialde. The corresponding values for
FTD were 2.0% (2 cases) in El Prat, 0.1% in Munguialde
(1 case).
The common age- and sex-specific pattern for all surveys
can be summarized as follows: 1) an increase in dementia
prevalence with age across sex groups, higher for AD than
for VD; and, 2) a higher prevalence of dementia among
women (Figure 2).
The logistic regression results (Additional File 3) pointed
to a significantly higher prevalence of dementia in women
OR 1.45 (95%CI 1.27 - 1.66), increasing with age and dif-
fering by place of residence. The prevalence of dementia in
both sexes in El Prat proved significantly higher than that
in some of the reanalyzed surveys (ZARADEMP, Zaragoza
and Bidasoa). The overall OR variation between Gerona
and Bidasoa was five-fold. Alzheimer's disease preva-
lences of Spanish-reanalyzed sub-populations referred to
El Prat showed significant departures in two surveys: Bida-
soa, OR = 0.42 (95% CI 0.32 - 0.55), and Pamplona, OR
= 1.35 (95% CI 1.03 - 1.77). For VD, with few populations
available for comparison, differences were significant
when Gerona, OR = 5.00 (95% CI 3.06 - 8.16), and
Toledo, OR = 2.05 (95% CI 1.12 - 3.73), were considered.
ORs for the oldest age group showed a seven-fold and
eighteen-fold increase for VD and AD respectively.
Results of reanalysis by type of diagnosing specialist, liv-
ing environment and level of participation are reported in
Additional File 4. Lower prevalence of AD, VD and overall
dementia were reported by surveys carried out by psychi-
atrists compared to neurologists and geriatricians. Similar
prevalence of AD and higher prevalence of VD among
men were found when diagnosis was conducted by geria-
tricians as opposed to neurologists. Reanalyzed suburban
populations of both sexes had a lower VD prevalence, and
higher prevalence of AD than urban sub-populations did.
Significantly lower prevalences of dementia, AD and VD
were systematically found when participation was below
<85%. The only unreported survey analyzed (Bidasoa)
showed lower dementia prevalence when weighted
against published surveys, OR = 0.32 (95% CI 0.24 -
0.44).
Discussion
The present study is a comprehensive, comparative
approach to the prevalence of dementia and its subtypes
in Spanish populations. The most relevant findings can be
summarized as follows: 1) dementia prevalence was
highly variable across reanalyzed sub-populations, 2)
dementia prevalence attributable to AD is higher among
women; 3) dementia prevalence varied as a result of the
composition of the diagnostic team (neurologist, psychi-
atrist, geriatrician, psychologist), the municipality cate-
gory (urban, suburban, urban-mixed) and the percentage
of participation of originally screened participants. Incon-
sistent results across studies may be whether due to the
diverse designs used across studies or due to actual preva-
lence variations caused by changes in incidence or sur-
vival. Since there are limitations due to study power, these
results should be taken cautiously.
Although the present study incorporated three surveys not
previously reanalyzed [1], it lacked information on theBMC Neurology 2009, 9:55 http://www.biomedcentral.com/1471-2377/9/55
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prevalence of dementia in Southern Spain. This may be
particularly misleading given that cardiovascular and cer-
ebrovascular mortality is reportedly higher in Southern
Spain [2,22]. Moreover, prevalence of vascular risk factors
(low folic acid intake, hypercholesterolemia, arterial
hypertension, diabetes mellitus and smoking habit) is
also higher in this region [23,24]. Unfortunately, surveys
conducted in areas where a high mortality due to stroke
have been reported (South-West Spain (Alcoi/Bañeres and
Murcia) [22-25] could not enter the analysis.
Since variation in screening instruments and participation
level were modest (range 62%-92.4%), it could be argued
that differences in prevalence of dementia were largely
Age-specific prevalence of dementia, Alzheimer's disease and vascular dementia in reanalyzed Spanish populations by gender Figure 2
Age-specific prevalence of dementia, Alzheimer's disease and vascular dementia in reanalyzed Spanish popula-
tions by gender.BMC Neurology 2009, 9:55 http://www.biomedcentral.com/1471-2377/9/55
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caused by inconsistent methods across surveys. Leganés
study [10] implemented sequential screening methods
that may have induced losses at follow up. On the other
hand, Leganés and Toledo studies [9,10] may have shown
an artifactually high sensitivity resulting from the clinical
evaluation of a large group of negatively screened partici-
pants. However, these shortcomings may have not been
highly detrimental to the internal validity of these studies
since the prevalence reported for Leganés and Toledo fell
within the range of variation of other surveys (see Figure
2).
Regarding specialist-specific diagnostic patterns, although
there is some evidence suggesting that psychiatrist
approach dementia differently as opposed to other medi-
cal professionals [26], our findings may be considered
artifactual. First, there is only one study involving a single
geriatrician, and he happened to be assisted by a psychia-
trist [9]. Therefore specific diagnostic patterns for geriatri-
cians and psychiatrists can not be clearly disentangled.
Second, the seemingly high likelihood of dementia diag-
nosis associated to geriatricians was limited to vascular
dementia (Additional File 4). Third, Toledo is located in
the mid-South of the country were cardiovascular mortal-
ity has been found to be higher [2], which suggests further
that differences found in Toledo may not be solely attrib-
utable to the background of the diagnosticians. In sum-
mary, it suffices to say that variation in the background of
diagnostic teams across studies may have induced some
degree of heterogeneity to dementia prevalence. However,
the limited number of studies and the various composi-
tions of diagnostic teams preclude any specific conclusion
as regards to univocal relationships between a given spe-
cialist and over- or under-diagnostic trends.
The impact of new entities in recent surveys, such as FTD
or LBD in El Prat, or FTD in Bidasoa, may have replaced
cases labeled as mixed dementia in earlier surveys, thus
leaving the proportion of AD relatively unchanged. The
high prevalence of VD reported in Gerona may be attrib-
uted to less restrictive diagnostic criteria [1,27-30].
A visual comparison of selected age- and sex-specific prev-
alence reported in European populations [31-36] suggests
that the variation of dementia prevalence in Spain may be
higher (Figure 3). Again, differences may have been
caused by the varying methodological features of the stud-
ies under analysis. Studies in El Prat [17] and Mungialde
[18] showed lower prevalences of LBD in these Spanish
populations when compared to the European popula-
tions of Kuopio (Finland) and Islington (UK) [37,38].
This could also be attributed to differing methods, partic-
ularly diagnostic standards used for LBD.
The number of dementia and AD patients in the Spanish
population (age  70 years) based on El Prat prevalence
was: 10.9% (95% CI 9.4% - 12.3%) and 608,000 cases
(95%CI 526,000 - 689,000) for dementia; and 7.7%
(95% CI 6.4% - 9.0%) and 431,000 cases (95%CI
359,000 - 502,000) for AD, respectively. However, these
values, while similar to those found in other surveys, may
not allow a valid extrapolation to the whole Spanish pop-
ulation.
Traditionally, differences in prevalence are attributed to
methods, incidence, survival and migration [39]. The
available evidence on incidence of dementia and its sub-
types in Spanish populations is sparse, making it hard to
attribute the differences observed to incidence variations.
An exception that could well fit our findings is the study
Age-specific prevalence of dementia, Alzheimer's disease and vascular dementia in European and El Prat populations, data for  both sexes Figure 3
Age-specific prevalence of dementia, Alzheimer's disease and vascular dementia in European and El Prat pop-
ulations, data for both sexes.BMC Neurology 2009, 9:55 http://www.biomedcentral.com/1471-2377/9/55
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conducted in Girona, which offered 23.2 and 10.8 per
1000 person-years for dementia and AD, respectively, for
those aged 75 years or more [27]. Regarding disease dura-
tion and survival of dementia subtypes, while differences
exist in terms of higher mean duration of AD, lower mean
duration of FTD (6.2 versus 4.2 mean years [40]), and
shorter duration of dementia with clinical vascular com-
ponents [41], it seems that the impact of these factors on
prevalence is still difficult to estimate. Most studies show
a slower increase of age-specific prevalence of VD with age
as opposed to age-specific prevalence of AD, which may
be attributable to shorter survival. Methodological aspects
affecting under-diagnosis in Central Spain surveys have
been pin-pointed by Bermejo et al. [42] and have been
observed here, particularly those related to non-participa-
tion and screening validation. Such problems might
account for the lower dementia prevalence of the unre-
ported survey.
Conclusion
Prevalence of dementia and AD in Central and North-
Eastern Spain is higher in females, increases with age, and
displays considerable geographic variation that may be
method-related. Prevalence figures were similar or lower
than those found in Western Europe. The present reanaly-
sis indicated that some 600,000 and 400,000 people have
dementia and AD in Spain, respectively. However, extrap-
olation should be taken cautiously until surveys con-
ducted in Southern Spain are available.
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